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Background: It has been shown in several studies that survival in cancer patients who were operated on by a
high-volume surgeon was better. Why then do all patients not benefit from treatment by these experienced
surgeons? The aim of our work was to study the hypothesis that in breast cancer, geographical isolation and the
socio-economic level have an impact on the likelihood of being treated by a specialized breast-cancer surgeon.
Methods: All cases of primary invasive breast cancer diagnosed in the Côte d’Or from 1998 to 2008 were included.
Individual clinical data and distance to the nearest reference care centre were collected. The Townsend Index of
each residence area was calculated. A Log Rank test and a Cox model were used for survival analysis, and a
multilevel logistic regression model was used to determine predictive factors of being treated or not by a
specialized breast cancer surgeon.
Results: Among our 3928 patients, the ten-year survival of the 2931 (74.6 %) patients operated on by a high-
volume breast cancer surgeon was significantly better (LogRank p < 0.001), independently of age at diagnosis, the
presence of at least one comorbidity, circumstances of diagnosis (screening or not) and TNM status (Cox HR = 0.81
[0.67-0.98]; p = 0.027). In multivariate logistic regression analysis, patients who lived 20 to 35 minutes, and more
than 35 minutes away from the nearest reference care centre were less likely to be operated on by a specialized
surgeon than were patients living less than 10 minutes away (OR = 0.56 [0.43; 0.73] and 0.38 [0.29; 0.50],
respectively). This was also the case for patients living in rural areas compared with those living in urban areas
(OR = 0.68 [0.53; 0.87]), and for patients living in the two most deprived areas (OR = 0.69 [0.48; 0.97] and 0.61 [0.44;
0.85] respectively) compared with those who lived in the most affluent area.
Conclusions: A disadvantageous socio-economic environment, a rural lifestyle and living far from large specialized
treatment centres were significant independent predictors of not gaining access to surgeons specialized in breast
cancer. Not being treated by a specialist surgeon implies a less favourable outcome in terms of survival.* Correspondence: jgentil@cgfl.fr
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As shown in many studies, being treated in a specialized
medical centre or by a high-volume surgeon is an inde-
pendent prognostic factor for survival in patients with
cancer, breast cancer particularly [1-9]. Moreover it is
now well known that the socio-economic level is also an
independent factor of survival in women with breast
cancer [10-13]. For some cancers, socioeconomic
deprivation and the distance to reference care centres
have been studied and shown to be predictive factors of
access to specialized care [14,15], but to our knowledge
this has not been studied for breast cancer. In addition,
there are disparities between a country’s socioeconomic
level and rural/urban distribution: in the United States
of America and the United Kingdom, city centres tend
to be occupied by the most deprived people, whereas the
wealthy live in suburbs around the cities. In France, it is
the other way around: the most privileged classes live in
the centre of big cities, whereas the most deprived
people live further away in the suburbs or in rural towns.
This study is one of the first to analyse the impact of
surgeons’ experience on survival and the link between
social characteristics and access to specialized surgeons.
In our population, we first studied the impact on sur-
vival of being operated on by a specialized breast cancer
surgeon. We then determined whether the educational,
social and economic environment of patients, the fact of
living in a town or in the countryside, and the distance
to the nearest reference care centre, independently of in-
dividual characteristics, such as age or stage at diagnosis,
had an impact on being treated by one of the specialized
breast cancer surgeons, all of whom work in one of the
two reference care centres of the district.Methods
Patients
We used the data from the Breast Cancer Registry of
Côte d’Or, which has collected exhaustive and continu-
ous medical information on all patients with breast
cancer in the French administrative district of Côte
d’Or, since 1982. The registry is part of the FRANCIM
Network and as such, its exhaustiveness and data qual-
ity are regularly checked by the French Institute of
Health and Medical Research (INSERM) and the Inter-
national Agency for Research on Cancer (IARC). All
cases of primary invasive breast cancer diagnosed over
a period of eleven years, between 1st January 1998 and
31st December 2008 in women living in the Côte
d’Or, were included. The Breast and Gynaecologic
Cancer Registry of Cote d’Or was approved by the
CNIL (National Commission on Informatics and Liber-
ties) for the collection and recording of data for re-
search purposes (authorization number DR-2012-038).Data collection and studied variables
High-volume surgeons were defined as those who had
performed more than 100 breast cancer operations
(from 130 to 602) during the study period: 8 (8.7 %) sur-
geons accounted for 74.6 % of all interventions. They all
worked in one of the two reference care centres of the
district, four in the private centre and four in the public
centre, both located in the regional capital. Reference
cancer care centres have been defined by the French
Public Health authorities. In Côte d’Or it corresponds to
the two highest-volume centres for breast cancer treat-
ment, where more than 90 % of primary breast cancer
surgery is performed.
Individual data
Age at diagnosis, year of diagnosis, TNM stage, the pres-
ence of at least one comorbid condition (diabetes, arter-
ial hypertension, obesity, neurological and psychiatric
diseases), time to travel to the nearest reference care
centre by car and the circumstances of diagnosis were
collected. All of the patients were staged according to
the system described in the 5th TNM edition [16]. Sta-
ging was based on pathological findings; clinical infor-
mation was used when pathological data were missing.
The T stage was divided into three classes: T1, T2 and
T3-T4, and the N and M stages into two classes, N+/N-
and M+/M-. Time to the nearest cancer reference care
centre was calculated using MAPINFO 9.1 (MapInfo
Corporation), CHRONOMAP (Magellan engineering)
and the Multinet Teleatlas road database, and divided
into four classes: less than 10 minutes, 10 to 20 minutes,
20 to 35 minutes and more than 35 minutes. The cir-
cumstances of diagnosis were divided into 2 classes:
patients who were diagnosed with cancer within the
context of a screening program, and those with tumours
discovered on clinical symptoms.
The year used for place of residence variables was the
year of diagnosis.
Aggregate data
For all patients, we collected the INSEE (National Insti-
tute for Statistics and Economic Studies) socioeconomic
aggregate data of their residence IRIS (Merged Islet for
Statistical Information) and we calculated the Townsend
index for each IRIS. The Townsend Index is a
deprivation score calculated from four aggregated vari-
ables: the percentage of economically active residents
aged 16-59/64 who are unemployed, the percentage of
private households that do not possess a car, the per-
centage of private households that are not owner-
occupied and the percentage of private households with
more than one person per room [17] . The Townsend
index was divided into quintiles. We also studied access
to a reference surgeon according to whether the place of
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defined by the Insee, as an IRIS including fewer than
10,000 inhabitants and not located in an urban area.
Statistical analysis
Continuous variables were described as means, standard
deviations and medians. Qualitative variables were given
as percentages.
Survival was calculated from the date of diagnosis to
the date of death or last follow-up. Overall survival was
estimated using the Kaplan Meier method, and survival
curves were compared using the Log-Rank test. For
multivariate analysis, the Cox regression model was ap-
plied. Hazard Ratios (HR) and their 95 % confidence
intervals were calculated. Age and stage at diagnosis,
year of diagnosis, the presence of comorbidities and the
circumstances of the diagnosis (screening or not) were
included in the multivariate model as adjustment vari-
ables. Multivariate Cox proportional hazards’ modelling
was applied to assess the independent prognostic effect
for crude survival.
Our population presented a clear multilevel structure
with patients (level 1) nested within the IRIS (level 2).
The association between geographical and socioeco-
nomic factors and being operated on by a high-volume
surgeon was investigated using a multilevel logistic
model. Univariate logistic regression was performed, giv-
ing p-values and Odds Ratios with their 95 % confidence
intervals. All variables with a p value less than 0.05 were
included in the multivariate model, always with age and
stage as adjustment variables. Multivariate analysis of
the predictive factors associated with being operated on
by a high-volume breast-cancer surgeon was carried out
using a multilevel logistic regression analysis: individual
data were level one, aggregate data were level two. Level
2 variance and the variance partition coefficient, which
represents the percentage of variance explained by the
level 2, are given.
All analyses were carried out using SAS v 9.1 software
and the final significance level was set at p < 0.05.
Results
Population
Our eleven-year registry population included 4646
patients. Among them, 3956 (85.1 %) had undergone
surgery for their primary tumour. For 28 patients, the
surgeon’s name was missing; these patients were there-
fore excluded. The characteristics of the 3928 remaining
patients, according to the type of surgeon (high-volume
or not) are presented in table 1. The mean age of our
patients was 60.1 years old, and 2931 (74.6 %) were
operated on by a high-volume surgeon. The proportion
of operations by year in the two groups was 69.3 % in
1998 and then 77.6, 75.3, 71.7, 72.6, 66.6, 73.0, 79.3,79.5, 77.3 and 78.8 % for consecutive years between
1999 and 2008, respectively.Follow-up and survival according to whether or not the
patient was operated on by a high-volume surgeon
The follow-up was available for 3924 (99.9 %) patients:
3365 (85.8 %) women were still alive and 559 (14.2 %)
had died.
Figure 1 shows the overall survival curves (Kaplan-
Meier) according to the surgeon class: high-volume
breast-cancer surgeon (surgeon class = 1) or not (sur-
geon class = 2). Table 2 shows the proportions, the Log-
Rank test and the results of the Cox multivariate analysis
for overall survival according to the surgeon’s class.
The multivariate survival analysis highlighted the fact that
patients who were operated on by a high-volume breast-
cancer surgeon had significantly better survival (Hazard
ratio HR=0.81, 95%CI= [0.67-0.98]; p =0.027), independ-
ently of age, year of diagnosis, TNM status, the presence of
at least one comorbidity and the circumstances of diagno-
sis. As expected, age class and T, N and M status were also
significant independent prognostic factors.
The presence of at least one comorbidity was a significant
factor in univariate analysis, but no longer so in multivariate
analysis. Indeed, it is strongly linked to the size of the most
advanced tumour, to a positive N stage and the third age
group (correlation coefficient p< 0.001 for all).Prognostic factors of being operated on by a
high-volume breast-cancer surgeon
The univariate logistic regression model, which analyzed
the relationship between the geographic and socioeco-
nomic characteristics of patients and the likelihood of
being operated on by a high-volume surgeon, showed that
all variables were significant, except for node and metasta-
sis status, which were then excluded from the multivariate
analysis. The results of the univariate and multilevel logis-
tic regression analyses are presented in table 3.
The circumstances of the diagnosis remained significant
in multivariate analysis: detection of the cancer during a
mass screening programme, or during individual screening
was a predictor of being operated on by a specialized sur-
geon. Patients who lived 20 to 35 minutes, and more than
35 minutes from the centres were less likely to be oper-
ated on by one of the high-volume breast-cancer surgeons
than were patients who lived less than 10 minutes by car
from one of the two reference care centres of the district.
(OR=0.56 [0.43; 0.73] and 0.38 [0.29; 0.50] respectively;
p < 0.001). This was also the case for patients living in a
rural area (OR=0.68 [0.53; 0.87]; p = 0.002). Similarly,
patients living in the two most deprived areas were less
likely to be operated on by one of the high-volume breast-
cancer surgeons than were patients living in the most
Table 1 Characteristics of patients according to the surgeon class (high-volume or not)
Total N= 3928 High-volume surgeon N=2931 Others N= 997 P for
heterogeneityN % N % N %
Individual data
Age
< 50 years old 946 24.1 702 23.9 244 24.5
<0.00150 to 74 years old 2438 62.1 1857 63.4 581 58.3
> 74 years old 544 13.8 372 12.7 172 17.2
Circumstances of diagnosis
Screening 1907 51.1 1501 53.2 406 44.8
<0.001Not screening 1823 48.9 1323 48.8 500 55.2
Unknown 198
T Stage - size
T1 2875 75.7 2185 77.1 690 71.6
<0.001
T2 767 20.2 548 19.3 219 22.7
T3 and T4 156 4.1 101 3.6 55 5.7
Unknown 130
N Stage - nodes
N0 2591 68.2 1936 68.2 655 68.1
0.962N1 and more 1211 31.8 904 31.8 307 31.9
Unknown 126
M Stage - metastasis
M0 3809 98.2 2843 98.3 966 98.0
0.500M1 69 1.8 49 1.7 20 2.0
Unknown 50
At least one comorbidity
Yes 861 21.9 627 21.4 234 23.5
0.171
No 3067 78.1 2304 78.6 763 76.5
Time to the nearest reference cancer care centre
< 10 minutes 1153 29.3 917 31.3 236 23.7
<0.001
10 to 20 minutes 1049 26.7 831 28.4 218 21.8
20 to 35 minutes 599 15.3 438 14.9 161 16.2
> 35 minutes 1127 28.7 745 25.4 382 38.3
Aggregate data
Place of residence
Rural 1067 27.2 746 25.5 321 32.2
<0.001Urban 2860 72.8 2184 74.5 676 67.8
Unknown 1
Townsend index
Quintile 1 (most affluent) 323 8.2 260 8.9 63 6.3
0.021
Quintile 2 557 14.2 432 14.8 125 12.5
Quintile 3 484 12.3 363 12.4 121 12.1
Quintile 4 722 18.4 531 18.1 191 19.2
Quintile 5 (most deprived) 1839 46.9 1342 45.8 497 49.9
Unknown 3
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Figure 1 Overall survival curves (Kaplan-Meier) according to surgeon class, high-volume breast cancer surgeon (surgeon class = 1) or
not (surgeon class = 2) (p < 0.001).
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respectively; p = 0.013).
The adjusted total variance between patients in the
IRIS can be partitioned into variance between IRIS
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<50 to 74 years old 89.6





















* CI: Confidence Interval.variance can be broken down as follows: variance in
the individual level was calculated at 249.7 (standard
error SE = 3.5), variance in level 2 was calculated at
25.5 (6.1), and the variance partition coefficient was













3.31 (2.71-4.04) < 0.001
0.001
1
1.67 (1.35-2.05) < 0.001











0.54 (0.43-0.68) < 0.001
1
Table 3 Remoteness and patients’ socio-economic characteristics: univariate and multilevel logistic regression analysis
as predictive factors of being operated on by a high-volume breast cancer surgeon
Univariate logistic regression analysis Multilevel logistic regression analysis
Odds ratio (95 % CI*) p-value Odds ratio (95 % CI*) p-value
Individual data
Age
< 50 years old 0.90 (0.76; 1.07)
<0.001 0.17950 to 74 years old 1
> 74 years old 0.68 (0.55; 0.83)
T Stage - size
T1 1
<0.001 0.189T2 0.79 (0.66-0.95)






Not screening 0.72 (0.62; 0.83) 0.78 (0.66-0.93)
Time to go to the nearest reference cancer care centre




10 to 20 minutes 0.98 (0.80; 1.21) 0.86 (0.68-1.07)
20 to 35 minutes 0.70 (0.56; 0.88) 0.56 (0.43-0.73)
> 35 minutes 0.50 (0.42; 0.61) 0.38 (0.29-0.50)
Aggregate data
Place of residence










Quintile 2 0.84 (0.60; 1.18) 0.84 (0.58-1.21)
Quintile 3 0.73 (0.52; 1.03) 0.74 (0.52-1.08)
Quintile 4 0.67 (0.49; 0.93) 0.69 (0.48-0.97)
Quintile 5 (most deprived) 0.65 (0.49; 0.88) 0.61 (0.44-0.85)
* CI: Confidence Interval.
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Since the Calman and Hile report in 1995 [18] , the
trend in European countries is to concentrate care
supply in specialized cancer-care centres. In France,
the Cancer Plan and the ministerial decree of March
29th 2007, which established the minimal threshold
for cancer operations illustrates this intention to con-
centrate cancer care. This policy decision was based
on the hypothesis that patients are more likely to re-
ceive high-quality treatment if their surgeon has ex-
perience in operating on their particular cancer. This
hypothesis is confirmed in our study: survival in
patients operated on by one of the highest-volume
breast cancer surgeons was significantly higher than
in others.
Our study has several limits. First of all, the survival
analysis did not take into account all of the possible con-
founding factors. Moreover, in order to simplify theanalysis, we established a threshold to define two classes
of surgeons: we used a threshold of 100 operations, as
we had done several survival analyses using various cat-
egories of reference surgeons: there was no significant
difference among surgeons who had operated on more
than 100 breast cancers, but there was a significant dif-
ference between the above surgeons and those who had
done fewer than 100 operations, among whom there was
no significant difference either.
In addition, in practice, among the 92 surgeons who
had operated on at least one breast cancer between 1998
and 2008, the eight who had performed the most opera-
tions, in a regular manner during their years of practice,
and were known to be surgeons of the department spe-
cialized in breast cancer surgery, were those who had
done more than 100 operations each, the ninth and the
following surgeons had all done less than 100 operations
over the study period.
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analysis for age, year of diagnosis, TNM stage, comor-
bidities and the circumstances of the diagnosis, in order
to minimize the number of confounding factors. In con-
trast, our analysis was not adjusted for other cancer
treatments, notably chemotherapy and radiotherapy,
which also have an impact on survival. But, very often,
surgery is the first step in the treatment, and the surgeon
or the centre the patient is referred to is the gateway to
the rest of the treatment. Access to one of these sur-
geons is therefore a prognostic factor in breast cancer.
More than a quarter of our patients was not referred to
and did not see a specialized surgeon.
The results of our study suggest that remoteness from a
reference care centre, meaning remoteness from a regional
capital, and a socioeconomically deprived environment
have an impact on access to surgeons specialized in breast
cancer. The most deprived patients and patients who lived
far from their regional reference care centre for breast
cancer were less likely to be operated on by a high-volume
surgeon. Our study showed that the probability of being
operated on by a specialized surgeon is inversely propor-
tional to the socio-economic level of the place of residence
as determined by the IRIS. Though the difference was not
statistically significant for the 2nd and 3rd quintiles in
comparison with patients of the most affluent Townsend
Index quintile, patients of the two most deprived quintiles
were respectively 1.5 and 1.6 times more likely to be oper-
ated on by a non-specialist surgeon.
The same was true for remoteness; there was no signifi-
cant difference between patients who lived less than 10
minutes by car, and those who lived between 10 and 20
minutes by car from one of the two reference treatment
centres of the Cote d’Or. However, patients who lived 20
to 35 and more than 35 minutes away from a reference
care centre were respectively 1.8 and 2.6 times more likely
to be operated on by a non-specialist surgeon than were
patients living closest to the centres. In our study, the like-
lihood of being treated by a high-volume surgeon
decreased with distance from the specialized centre. This
means that unfavourable geographical and social charac-
teristics have to be considered as potential predictive fac-
tors of a less than optimal surgical result, of potential
recurrence and worse survival, as suggested by a French
report on the risk of being less well treated in a low-
volume hospital [19]. Moreover, patients who are less
likely to be treated in reference centres are generally the
same as those who are less likely to receive optimal overall
disease management. Geographical and socioeconomic
disparities remained significant even after adjustment for
TNM status and age at diagnosis. Our findings showed a
trend towards the results of similar studies about cancer
treatment in reference centres, especially for colorectal
cancer [14,15].Another interesting point is that women who were diag-
nosed within the context of a screening program were sig-
nificantly more likely to be operated on by a high-volume
surgeon than were patients who were diagnosed on clin-
ical symptoms. This parameter was included in the ana-
lysis as an adjustment variable to study the hypothesis that
patients with disadvantageous geographic and socio-
economic characteristics were less likely to be referred to
a high-volume surgeon because they were less likely to
take part in mass screening programs. The result under-
pins the hypothesis that women who take part in mass
screening programs for breast cancer are indeed more
likely to be operated on by a specialized surgeon and this
independently of remoteness and socio-economic level of
their place of residence.
This raises other hypotheses on cancer detection and
treatment patterns that need to be explored in specific
studies.
Conclusions
Though we showed that socioeconomic deprivation and
remoteness were independent predictors of access to a
specialized surgeon, and as such, could be linked to sur-
vival, we were unable to explain why underprivileged
patients or those living far from reference care centres
were less likely to be referred to specialized surgeons.
Though it can be understood that patients who live far
from a reference care centre may prefer to be treated lo-
cally rather than travel, it is difficult to explain why the
most deprived patients, independently of the distance,
were less likely to receive specialized care.
Nevertheless, social and geographical disparities with
regard to access to care for patients with breast cancer
remain, and these disparities can affect the chances of
survival. Improvements need to be made in the quality
of care in non-reference care centres, or in the distribu-
tion of specialized care centres around the country, to
avoid aggravating these differences.
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